Code | CSB-EP001840HU |
Abbreviation | Recombinant Human ANXA2 protein |
MSDS | |
Size | US$256 |
Order now | |
Image | |
Have Questions? | Leave a Message or Start an on-line Chat |
The recombinant Human ANXA2 protein is encoded by the gene of ANXA2 (2-339aa). The gene of ANXA2 was cloned in a system (E.coli) that supported the expression of ANXA2. Modification of ANXA2 by recombinant DNA technology could lead to the expression of the target protein. The protein was fused with N-terminal 6xHis-SUMO tag in the production. The purity is 90% determined by SDS-PAGE.
ANXA2 is a protein coding gene that encodes Annexin A2 also known as annexin II. According to some studies, ANXA2 may have the following features.
ANXA2 plays a key role in enhancing the invasiveness of multidrug resistant human breast cancer cells. Mesenchymal stem cells promote the occurrence of liver cancer through the interaction of lncRNA-MUF with ANXA2 and miR-34a. Anxa2 combines with STAT3 to promote the epithelial to mesenchymal transition of breast cancer cells. ANXA2 promotes the progression of esophageal cancer by activating the MYC-HIF1A-VEGF axis. The up-regulation of ANXA2 gene promotes the proliferation and invasion of breast cancer MCF-7 cells. ANXA2 is identified as a specific bleomycin target, which induces pulmonary fibrosis by blocking the autophagy flux mediated by TFEB. P-glycoprotein is associated with Anxa2 and promotes the invasion of multidrug resistant breast cancer cells. Circular RNA analysis shows that circular RNA from ANXA2 can be used as a new biomarker for multiple sclerosis.
There are currently no reviews for this product.